Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-08

Clinical Trial Update: Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

View source ↗

Summary

This clinical trial update reports the observational study evaluating safety and efficacy of Norditropin (somatropin) in adults with growth hormone deficiency. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Status: COMPLETED